Ocata Therapeutics

Stem cell-based therapies to treat dry age-related macular Degeneration (Dry AMD) and stargardt’s macular degeneration.

placeMarlborough, Massachusetts, United States calendar_todayFounded 1994 groups37 employees language ocata.com

Innovation

20 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 3,023 times.

YearFilings
20121
20142
201511
20169
20176
20181
20192

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon